GAMMAGARD LIQUID | Viral Safety

healthcare professionals > why GAMMAGARD LIQUID > viral safety

the science of

viral safety

GAMMAGARD LIQUID 10% is treated with a dedicated 3-step process specifically designed for viral inactivation/removal.¹

GAMMAGARD LIQUID 10% is sourced and processed exclusively from plasma collected at FDA-registered donor sites.¹

Donations are individually screened for HBsAg and for antibodies to HIV-1, HIV-2, and HCV*
Mini-pools of collected plasma are further tested with FDA-approved nucleic acid testing
IgGs are purified from plasma pools with a modified Cohn-Oncley fractionation process, and cation and anion exchange chromatography

Learn about the steps Baxter is taking to protect GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% against specific viral agents.

As with all plasma-derived therapeutics, the potential to transmit infections agents cannot be totally eliminated.

Please see Important Safety Information and Full Prescribing Information for GAMMAGARD LIQUID.

View References

*EMCV (encephalomyocarditis virus), HAV (hepatitis A virus), MMV (mice minute virus), B19V (human parvovirus B19), HBsAg (hepatitis B surface antigen), HIV (human immunodeficiency virus), HCV (hepatitis C virus)